Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Geller

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
The effect of unrelated donor marrow transplantation on health-related quality of life: a report of the unrelated donor marrow transplantation trial (T-cell depletion trial)Elizabeth M Altmaier, Marian Ewell, Richard McQuellon, et al.
Circulation|February 5, 2003
Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imagingRaymond Y Kwong, Adam E Schussheim, Suresh Rekhraj, et al.
BMC Public Health|October 12, 2023
Parents, but not their children, demonstrate greater delay discounting with resource scarcityAlyssa M Button, Rocco A Paluch, Kenneth B Schechtman, et al.
British Journal of Haematology|April 29, 2006
Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantationRamaprasad Srinivasan, Yoshiyuki Takahashi, J Philip McCoy, et al.
Bone Marrow Transplantation|September 9, 2024
Durable remission of refractory and advanced stage mycosis fungoides/sezary syndrome utilizing an "outpatient" alemtuzumab, fludarabine-based reduced intensity allogeneic hematopoietic cell transplantationPhuong Vo, Ramaprasad Srinivasan, Enkhtsetseg Purev, et al.
Clinical Trials (London, England)|February 16, 2012
Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) StudyFrederick L Brancati, Mary Evans, Curt D Furberg, et al.
JAMA|June 14, 2023
Family-Based Behavioral Treatment for Childhood Obesity Implemented in Pediatric Primary Care: A Randomized Clinical TrialLeonard H Epstein, Denise E Wilfley, Colleen Kilanowski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2014
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuriaJeremy Pantin, Xin Tian, Nancy Geller, et al.
The Pharmacogenomics Journal|October 8, 2024
Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patientsSamuel Huxley, James Moriarty, Mark A Hlatky, et al.
American Journal of Hematology|July 2, 2013
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromesJeremy Pantin, Xin Tian, Avni A Shah, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
The effect of unrelated donor marrow transplantation on health-related quality of life: a report of the unrelated donor marrow transplantation trial (T-cell depletion trial)Elizabeth M Altmaier, Marian Ewell, Richard McQuellon, et al.
Circulation|February 5, 2003
Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imagingRaymond Y Kwong, Adam E Schussheim, Suresh Rekhraj, et al.
BMC Public Health|October 12, 2023
Parents, but not their children, demonstrate greater delay discounting with resource scarcityAlyssa M Button, Rocco A Paluch, Kenneth B Schechtman, et al.
British Journal of Haematology|April 29, 2006
Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantationRamaprasad Srinivasan, Yoshiyuki Takahashi, J Philip McCoy, et al.
Bone Marrow Transplantation|September 9, 2024
Durable remission of refractory and advanced stage mycosis fungoides/sezary syndrome utilizing an "outpatient" alemtuzumab, fludarabine-based reduced intensity allogeneic hematopoietic cell transplantationPhuong Vo, Ramaprasad Srinivasan, Enkhtsetseg Purev, et al.
Clinical Trials (London, England)|February 16, 2012
Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) StudyFrederick L Brancati, Mary Evans, Curt D Furberg, et al.
JAMA|June 14, 2023
Family-Based Behavioral Treatment for Childhood Obesity Implemented in Pediatric Primary Care: A Randomized Clinical TrialLeonard H Epstein, Denise E Wilfley, Colleen Kilanowski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2014
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuriaJeremy Pantin, Xin Tian, Nancy Geller, et al.
The Pharmacogenomics Journal|October 8, 2024
Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patientsSamuel Huxley, James Moriarty, Mark A Hlatky, et al.
American Journal of Hematology|July 2, 2013
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromesJeremy Pantin, Xin Tian, Avni A Shah, et al.
Pageof 6